"Fat-dissolving injections" is one of the most searched phrases in UK aesthetics, and one of the most misleading. It sounds like one treatment. In practice it covers several products that work in different ways, carry different evidence and sit in different legal positions. This guide explains what is actually in the syringe, which fat it can and cannot help, who is allowed to prescribe and give it in each UK nation, and what clinics charge.
What fat-dissolving injections are: a bile salt that breaks fat cell membranes
The best-known products, Aqualyx and the licensed under-chin medicine Belkyra (sold as Kybella in the US), are built on deoxycholic acid. This is a bile acid your gut bacteria make naturally, and as its sodium salt it acts as a biological detergent. Injected into fat, it breaks open the outer membrane of fat cells. Nothing is "burned" or metabolised: the cells are simply lysed, and the effect is non-selective.
Non-selective matters. The bile salt would damage any cell it reached, and what protects muscle, skin and blood vessels is that their proteins bind the bile salt and blunt it, while fat is comparatively protein-poor. That is why depth and placement dominate the safety picture.
The visible result comes in two stages. The cells die quickly, then over the following weeks the body's clean-up cells clear the debris and the treated area remodels. Biopsies from the licensed product's trials show inflammation on day 1 and fat lobules shrinking by day 28. Swelling is part of how it works, not a side effect a clever protocol can remove, and results are never immediate.
One label, four products, four legal positions
The bile salt mechanism above is true of Aqualyx and Belkyra. It is not true of every product sold as "fat dissolving".
| Product | What is in it | Works by the bile salt mechanism? | UK legal position |
|---|---|---|---|
| Belkyra (Kybella in the US) | Synthetic deoxycholic acid | Yes | Licensed medicine, for fat under the chin only |
| Aqualyx | A deoxycholate bile salt in a buffered gel, no phosphatidylcholine | Yes | CE-marked as a device, supplied as an unlicensed medicine, prescription only |
| Phosphatidylcholine (PPC) products | Phosphatidylcholine, sometimes with sodium deoxycholate | Only where deoxycholate is added | Not authorised, and must not be used for any cosmetic purpose |
| Lemon Bottle | Marketed as riboflavin, lecithin and bromelain | No: marketed as free of deoxycholic acid | Sold as a cosmetic; classed in Switzerland as an unapproved medicine |
Belkyra went through full drug trials and holds a UK marketing authorisation, first granted in 2017, for moderate to severe fat under the chin only. Its maker has since withdrawn it in Ireland and taken it off the Australian market, so whether it is currently available in the UK should be checked with any clinic offering it.
Aqualyx has no UK marketing authorisation. It is CE-marked as a medical device, and its UK distributor supplies it as an unlicensed medicine, which means it can only be provided after a face-to-face consultation with a prescriber who takes clinical responsibility for its use. It is not "MHRA approved" or "licensed", whatever some clinic pages say, and the US FDA names it among fat-dissolving injections that are not FDA approved.
PPC products are the older "Flabjab" lineage. The MHRA's position, relayed by the JCCP, is that phosphatidylcholine is not authorised in the UK and "must not be used for any cosmetic purposes". Researchers later showed that in these mixtures it was the added bile salt, not the phosphatidylcholine, doing the work.
Lemon Bottle is marketed as a cosmetic, but Swissmedic has said it should be classified as a medicinal product, is not approved, and that its tested composition did not match the maker's declaration. Our comparison of Aqualyx and Lemon Bottle sets out what regulators have said about each.
Where they fit: small, localised pockets of fat, not weight loss
Deoxycholate injections are for a small, pinchable pocket of fat in someone whose weight is stable. They are not a weight-loss treatment: in the licensed product's early studies the injected bile salt returned to normal blood levels within about 12 hours with no meaningful change in blood fats, and nothing changes on the scales.
Before anything else, a new lump, a growing fat pad at the base of the neck, or swelling on one side of the chest should be seen by a GP. A buffalo hump, for example, is most often caused by Cushing's syndrome, and glandular breast tissue in men is not fat at all.
The areas, honestly ranked:
- Under the chin is the only area with randomised controlled evidence and a licensed product.
- Hips, flanks and the upper back were among the best-responding areas in the main Aqualyx series, but that series was uncontrolled.
- Upper arms and inner thighs were the least responsive areas in the same series.
The evidence, with its weaknesses. In the two pivotal under-chin trials of the licensed product, which enrolled 506 and 516 adults, only 13.4% and 18.6% of treated patients achieved a two-grade improvement on a five-point scale (FDA prescribing information): most responders saw a modest change. A 2023 meta-analysis found that all five randomised trials had industry sponsorship or potential industry bias. Those results are for a different deoxycholic acid product and are not Aqualyx results. No randomised trial of Aqualyx has been published. Its main series reported 76.7% "medical success" in 1,344 patients, but it was retrospective, physician-rated, written by authors connected with the manufacturer's training programme, and excluded 26.64% of patients whose weight changed by more than 5%.
The risks. In that Aqualyx series, 88.76% of patients had swelling in the first 72 hours and 72.58% had bruising. Nodules were reported in 16.36% there, but in 42% of 145 patients in independent reporting, most of them treated by less experienced doctors. Skin necrosis and chronic infection have been reported, including after injection by someone who was not a health professional. "No downtime" is not a defensible claim for any of these products.
Who may prescribe and give them
Across the UK, medicines law sets the floor. All medicines given by injection must be prescription-only, as the government has confirmed in a written parliamentary answer. An unlicensed medicine such as Aqualyx can only be ordered for an individual patient by a doctor, dentist, nurse independent prescriber, pharmacist independent prescriber or supplementary prescriber, under the MHRA's rules on unlicensed medicines, which also prohibit advertising them. The JCCP's prescribing statement says agents used for lipolysis must not be prescribed remotely: the prescriber assesses you face to face, and someone else may inject only under a Patient Specific Direction naming you, with the prescriber keeping responsibility.
On top of that, the rules differ by nation:
- England: there is no statutory register of aesthetic practitioners. A government consultation opened on 21 October 2026 on restricting high-risk procedures to doctors, dentists and independent-prescriber nurses, midwives and pharmacists; it closes on 13 January 2027 and does not name fat dissolving.
- Scotland: clinics where doctors, dentists, nurses, midwives or pharmacists provide services must register with Healthcare Improvement Scotland. The Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026 covers injected cosmetic procedures, including fat dissolving. Its restriction to permitted premises, such as HIS-registered clinics led by a prescriber, cannot start before 6 September 2027 and is not yet in force.
- Wales: there is currently no specific rule on who may give fat-dissolving injections.
- Northern Ireland: there is no licensing or required qualification for injectables, and in October 2026 the Department of Health said it had "no current plans" for a licensing scheme.
Wherever you live, the questions are the same: who is the prescriber, will you meet them in person, and where did the product come from?
What they cost in the UK, in market ranges
These are market ranges taken from UK clinic price lists and treatment directories in research compiled in August 2026. They describe the market, they are not our prices, and price is a poor way to choose a prescription-only treatment.
- Per session: a treatment directory put a typical session at about £395 to £495, with a smaller area such as the chin from about £250.
- Per area: one clinic listed the chin at £400 for one session or £999 for four, and a larger area such as the abdomen at £550 for one or £1,275 for four.
- Per vial: another clinic charged £250 per vial.
- The full spread runs from about £89 per vial to £850 per session for treatments that sound alike.
Per-vial and per-area prices do not compare: a large area can need up to 1.5 vials per 100 square centimetres, so a low per-vial headline can cost more in total. UK wholesale listings put the product at roughly £155 to £165 per vial, so a session priced well below that should prompt questions about where the product came from. The treatment is private; it is not offered on the NHS for cosmetic fat. Our guide to fat reduction costs in the UK sets these prices beside fat freezing, cavitation, HIFU and RF.
Weight-loss medication is a different tool for a different problem
Many of our readers are already taking, or considering, a prescription weight-loss medicine such as tirzepatide (Mounjaro) or semaglutide (Wegovy). These act on the whole body, through appetite and metabolism, and are prescribed against clinical criteria for people living with obesity. Fat-dissolving injections act only where they are injected and leave body weight unchanged.
So they are not alternatives. One addresses overall weight; the other, at most, a small stubborn pocket in someone whose weight is already stable. Because weight change confounds the results of local treatment, a prescriber assessing a local area will usually want your weight to have settled first. Our article on the difference between Mounjaro and Aqualyx goes into this further.
The short version
If you have a small pocket of fat that a stable weight has not shifted, a deoxycholate injection may be worth discussing with a prescriber, with realistic expectations about swelling, sessions and evidence. If the concern is overall weight, loose skin or a new lump, it is the wrong tool. Our treatment page sets out how consultations work, and VIVO Body Studio offers a face-to-face assessment at one of our clinics where a prescriber will tell you honestly whether your concern is localised fat at all. No result is promised.
Deoxycholate fat-dissolving injections: the honest summary
Pros
- They act on one small area, so they can change the shape of a pinchable pocket that has not shifted with a stable weight.
- Fat cells are destroyed rather than shrunk, and in trials of the licensed under-chin product most responders still held their result at three years.
- The under-chin area has genuine randomised, placebo-controlled evidence behind it, for the licensed deoxycholic acid product.
Cons
- There is no randomised trial of Aqualyx itself, and the main series behind it was uncontrolled and written by authors linked to the manufacturer.
- Swelling, bruising and tenderness are the norm, not the exception, and nodules, numbness and rare skin necrosis have been reported.
- They do nothing for overall weight, loose skin or glandular chest tissue, and results depend heavily on who is injecting.
Frequently Asked Questions
Are fat-dissolving injections a weight-loss treatment?
No. They destroy fat cells in one small treated area and do not change overall body weight or metabolism. They are a contouring treatment for a localised pocket of fat in someone whose weight is already stable.
Is Aqualyx licensed or MHRA approved?
No. Aqualyx has no UK marketing authorisation. It is CE-marked as a medical device and supplied in the UK as an unlicensed medicine, so it can only be provided after a face-to-face consultation with a prescriber who takes clinical responsibility for its use.
Is Lemon Bottle the same as Aqualyx?
No. Lemon Bottle is marketed as containing riboflavin, lecithin and bromelain and as free of deoxycholic acid, so it does not work by the bile salt mechanism. It is sold in the UK as a cosmetic, while the Swiss regulator has classed it as an unapproved medicinal product.
How many sessions are usually needed?
For the licensed under-chin product, most patients improve within 2 to 4 sessions, with a maximum of 6 at least 4 weeks apart. For Aqualyx there is no controlled data on session numbers; the main published series spaced sessions 4 to 7 weeks apart.
Can I have fat-dissolving injections while taking a weight-loss medicine?
That is a question for the prescriber who assesses you. The published Aqualyx series excluded patients whose weight changed by more than 5%, because weight change confounds the result, so treating a local area usually makes most sense once your weight has settled.
